
    
      This study will be an open-label, absorption, metabolism, and excretion study of
      [14C]-BVD-523 administered as a 600-mg (approximately 200 ÂµCi) oral dose to 6 healthy male
      subjects following a 2-hour fast from food (not including water) that follows breakfast.
    
  